C07D 277/32
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D277/32 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 3,725 US grants and 3,378 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,725
- Published applications
- 3,378
- Assignees
- 1,424
- Inventors
- 10,615
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 42 | 0 |
| 1978 | 37 | 0 |
| 1979 | 30 | 0 |
| 1980 | 42 | 0 |
| 1981 | 50 | 0 |
| 1982 | 42 | 0 |
| 1983 | 50 | 0 |
| 1984 | 47 | 0 |
| 1985 | 40 | 0 |
| 1986 | 39 | 0 |
| 1987 | 43 | 0 |
| 1988 | 42 | 0 |
| 1989 | 34 | 0 |
| 1990 | 58 | 0 |
| 1991 | 56 | 0 |
| 1992 | 51 | 0 |
| 1993 | 90 | 0 |
| 1994 | 54 | 0 |
| 1995 | 56 | 0 |
| 1996 | 67 | 0 |
| 1997 | 77 | 0 |
| 1998 | 55 | 0 |
| 1999 | 73 | 0 |
| 2000 | 58 | 0 |
| 2001 | 106 | 13 |
| 2002 | 83 | 101 |
| 2003 | 87 | 152 |
| 2004 | 89 | 191 |
| 2005 | 71 | 188 |
| 2006 | 83 | 158 |
| 2007 | 108 | 156 |
| 2008 | 102 | 161 |
| 2009 | 94 | 186 |
| 2010 | 139 | 204 |
| 2011 | 119 | 167 |
| 2012 | 142 | 124 |
| 2013 | 118 | 156 |
| 2014 | 162 | 164 |
| 2015 | 131 | 142 |
| 2016 | 116 | 129 |
| 2017 | 119 | 133 |
| 2018 | 79 | 114 |
| 2019 | 104 | 103 |
| 2020 | 71 | 107 |
| 2021 | 72 | 90 |
| 2022 | 64 | 104 |
| 2023 | 50 | 118 |
| 2024 | 55 | 97 |
| 2025 | 61 | 75 |
| 2026 | 35 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Polymorphs of Ponesimod15 Sep 2026US 12,735,391 B2Tapi Czech Industries S.R.O
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof18 Aug 2026US 12,709,603 B2vTv Therapeutics LLC
- Compound having inhibitory activity against O-glusacase and use thereof28 Jul 2026US 12,692,260 B2Medifron DBT Co., Ltd.
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
- Cgas antagonist compounds17 Sep 2026US 2026/0274808 A1Board of Regents, The University of Texas System
- 5-membered heteroaryl carboxamide compounds for treatment of hbv17 Sep 2026US 2026/0274823 A1Assembly Biosciences, Inc.
- Thiazole compounds as dgk¿ inhibitors17 Sep 2026US 2026/0274847 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase183US 5,409,944 AMerck Frosst Canada, Inc. · 1995
- Amide derivatives176US 4,636,505 AImperial Chemical Industries PLC · 1987
- Heterocyclic self-immolative linkers and conjugates164US 7,375,078 B2Genentech, Inc. · 2008
- Cephem derivative162US 4,278,793 AHoechst Aktiengesellschaft · 1981